Variables | HIV-infected patients (N = 116) | HIV-uninfected patients (N = 34) | p-values |
---|---|---|---|
Fever | 101 (87.1%) | 22 (64.7%) | 0.005 |
Lymphadenopathy | 37 (31.9%) | 13 (38.2%) | 0.537 |
Hepatomegaly | 42 (36.2%) | 6 (17.6%) | 0.059 |
Splenomegaly | 25 (21.6%) | 2 (5.9%) | 0.042 |
Cutaneous lesions | 47 (40.5%) | 14 (41.2%) | 1.000 |
Umbilicated lesions | 45 (95.7%) | 5 (35.7%) | |
Sweet’s syndrome | 0 | 5 (35.7%) | |
Pustular psoriasis | 1 (2.1%) | 1 (7.1%) | |
Chronic ulcer | 1 (2.1) | 0 | |
Subcutaneous nodule | 0 | 1 (7.1%) | |
Subcutaneous abscess | 0 | 1 (7.1%) | |
Panniculitis | 0 | 1 (7.1%) | |
Cough | 32 (27.6%) | 8 (23.5%) | 0.826 |
Anemia | 8 (6.9%) | 0 | 0.199 |
Diarrhea | 15 (12.9%) | 2 (5.9%) | 0.362 |
Arthritis/osteomyelitis | 0 | 5 (14.7%) | <0.001 |
Duration of symptoms (days) (Median, IQR) | 30 (14, 30) | 30 (14, 60) | 0.061 |